ARTICLE

Binding and Selective Detection of the Secretory N-terminal Domain of the Alzheimer Amyloid Precursor Protein on Cell Surfaces

Correspondence to: Volker Herzog, Institut für Zellbiologie, Ulrich-Haberland-Str. 61a, D-53121 Bonn, Germany.

The secretory N-terminal domain of the Alzheimer amyloid precursor protein (sAPP) evokes specific responses in cells on binding to their surfaces. Because APP is expressed in a large variety of cell types, the localization of sAPP binding requires detection techniques that selectively recognize sAPP as a ligand. For this purpose, we prepared antibodies against recombinant sAPP695 (sAPPrec) previously expressed in E. coli. Such antibodies were found to distinguish between sAPPrec and cellular APP or sAPP, as shown by immunocytochemistry and by immunoblot. In addition, they allowed the selective localization of bound sAPPrec on cell surfaces without any signal from cellular APP or sAPP. Saturation of sAPPrec binding to cell surfaces, as determined radiometrically, was reached at 10 nM [¹²⁵I]-sAPPrec. Binding was specific because it was almost completely inhibited by a 100-fold excess of unlabeled sAPPrec. This specificity of binding was confirmed by surface plasmon resonance spectroscopy. Binding of sAPPrec to cell surfaces occurred in patches and was dependent on the state of cell differentiation. The sAPPrec used in this study contains heparin binding sites, but enzymatic removal of cell surface associated heparin did not affect sAPPrec binding. Aldehyde fixation of cells strongly inhibited their ability to bind sAPPrec. The data point to a fixation-sensitive sAPPrec binding protein which is detectable in the form of patches and therefore is part of assembled cell surface microdomains. (J Histochem Cytochem 47:373–382, 1999)

Key Words: Alzheimer amyloid precursor protein, sAPPrec binding, cell surface, immunocytochemistry, microdomains

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Faye, C. Moreau, E. Chautard, R. Jetne, N. Fukai, F. Ruggiero, M. J. Humphries, B. R. Olsen, and S. Ricard-Blum Molecular Interplay between Endostatin, Integrins, and Heparan Sulfate J. Biol. Chem., August 14, 2009; 284(33): 22029 - 22040. [Abstract] [Full Text] [PDF]

				M. Gralle, M. G. Botelho, and F. S. Wouters Neuroprotective Secreted Amyloid Precursor Protein Acts by Disrupting Amyloid Precursor Protein Dimers J. Biol. Chem., May 29, 2009; 284(22): 15016 - 15025. [Abstract] [Full Text] [PDF]

				I. Caille, B. Allinquant, E. Dupont, C. Bouillot, A. Langer, U. Muller, and A. Prochiantz Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone Development, May 1, 2004; 131(9): 2173 - 2181. [Abstract] [Full Text] [PDF]

				D. E. Hansel, A. Rahman, S. Wehner, V. Herzog, C. J. Yeo, and A. Maitra Increased Expression and Processing of the Alzheimer Amyloid Precursor Protein in Pancreatic Cancer May Influence Cellular Proliferation Cancer Res., November 1, 2003; 63(21): 7032 - 7037. [Abstract] [Full Text] [PDF]

				M. G. Botelho, M. Gralle, C. L. P. Oliveira, I. Torriani, and S. T. Ferreira Folding and Stability of the Extracellular Domain of the Human Amyloid Precursor Protein J. Biol. Chem., September 5, 2003; 278(36): 34259 - 34267. [Abstract] [Full Text] [PDF]

				Y. Hashimoto, T. Niikura, T. Chiba, E. Tsukamoto, H. Kadowaki, H. Nishitoh, Y. Yamagishi, M. Ishizaka, M. Yamada, M. Nawa, et al. The Cytoplasmic Domain of Alzheimer's Amyloid-{beta} Protein Precursor Causes Sustained Apoptosis Signal-Regulating Kinase 1/c-Jun NH2-Terminal Kinase-Mediated Neurotoxic Signal via Dimerization J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 889 - 902. [Abstract] [Full Text] [PDF]

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact

The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 1999